Laboratory:Akiruno
- TOP
- gene-related test
- genetic tests for hematopoietic tumor
- minorBCR-ABL1mRNA(%)
Laboratory:Akiruno
○minorBCR-ABL1mRNA(%)
CODE:00G47 3
-
TEST NAME
SPECIMEN
REQUIREMENT
(mL) CONTAINER CAP COLOR STORE
TEMPERATURE
(STABILITY) TURNAROUND
TIME (DAY) METHODOLOGY REFERENCE RANGE
(UNIT) -
minorBCR-ABL1mRNA(%)
Blood (EDTA-2Na added)
7.0
PN7
(1 day)
3-5 RT-PCR (Real Time PCR)Real-time PCR
A type of nucleic acid amplification method based on the basic principle of PCR, which uses oligonucleotides that emit fluorescence upon decomposition to quantify target nucleic acids in real time by checking the fluorescent signal at each PCR cycle. A measurement method that enables
COMMENT
Avoid freezing.
Consignment days are Monday to Friday.
Please submit the sample immediately after collecting it.
Please avoid duplicate requests with other items.
This testing method increases the influence of contamination, so please be careful when handling the specimen.
This test can measure e1a2, but cannot measure e1a3 fusion mRNA. Additionally, if there is a mutation in the region where the primer and probe bind in the e1a2 fusion mRNA, measurement of minor BCR-ABL1 mRNA may not be possible.
About submission of hematopoietic tumor genetic testing
Please submit the specimen on the same day after collection.
Collect blood into the container shown below, mix well, and store in the refrigerator.
Please submit the specimen on the same day after collection.
Please avoid duplicate requests with other items.
This testing method increases the influence of contamination, so please be careful when handling the specimen.
CONTAINER
PN7 旧容器記号 A 4
EDTA-2Na入り (真空採血量7mL)
内容:EDTA-2Na 10.5mg
貯蔵方法:室温
有効期間:製造から2年
supplementary information
minor BCR-ABL1 mRNA (%) 報告内容について
事例 | minor BCR-ABL1/ABL1比 報告内容 |
報告コメント |
---|---|---|
minor BCR-ABL1 mRNA測定値が測定下限値13.58コピー/テスト未満の場合 | (13.58/ABL1 mRNA測定値) %未満 | なし |
minor BCR-ABL1 mRNA測定値が検出されなかった場合 | 検出せず | BCR-ABL1が検出されませんでした |
ABL1 mRNA測定値が10000コピー/テスト未満の場合 | 計算不能 | 別紙ラボレター※ |
※正報告書と合わせて、別紙報告書にて詳細をご報告いたします。